PNPLA3 and metabolic dysfunction-associated steatotic liver disease: PNPLA3-I148M has subsequently been associated with all aspects of NAFLD, including age at diagnosis [50]; hepatic steatosis [51]; disease severity [51]; fibrosis stage [51]; and HCC [52].